Remus Pharmaceuticals Limited (NSE:REMUS)

Remus Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 26, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	8,044	13,192	10,163	-	-	-
Market Cap Growth	-44.95%	29.81%	-	-	-	-
Enterprise Value	8,305	13,164	10,212	-	-	-
Last Close Price	690.00	1118.05	860.48	-	-	-
PE Ratio	25.21	45.38	49.53	-	-	-
PS Ratio	1.08	2.13	4.77	-	-	-
PB Ratio	2.38	4.67	5.80	-	-	-
P/TBV Ratio	2.70	5.34	6.83	-	-	-
P/FCF Ratio	359.11	439.73	-	-	-	-
P/OCF Ratio	118.64	189.00	752.80	-	-	-
EV/Sales Ratio	1.11	2.12	4.80	-	-	-
EV/EBITDA Ratio	16.15	29.25	35.56	-	-	-
EV/EBIT Ratio	16.96	30.04	36.68	-	-	-
EV/FCF Ratio	370.74	438.80	-	-	-	-
Debt / Equity Ratio	0.05	0.08	0.08	0.42	0.03	0.09
Debt / EBITDA Ratio	0.31	0.50	0.49	0.71	0.04	0.21
Debt / FCF Ratio	7.15	7.66	-	3.08	0.04	0.10
Asset Turnover	1.90	1.62	1.16	1.79	1.84	2.30
Inventory Turnover	9.08	11.26	7.53	22.88	8.96	14.50
Quick Ratio	0.87	1.11	0.99	0.97	0.44	0.58
Current Ratio	1.61	1.82	1.51	1.39	0.84	0.98
Return on Equity (ROE)	18.30%	16.79%	24.98%	66.14%	71.37%	40.49%
Return on Assets (ROA)	7.75%	7.15%	9.46%	26.40%	19.63%	8.89%
Return on Capital (ROIC)	12.30%	11.07%	16.07%	39.41%	52.34%	25.48%
Return on Capital Employed (ROCE)	13.10%	14.10%	14.50%	40.30%	63.30%	34.60%
Earnings Yield	4.17%	2.20%	2.02%	-	-	-
FCF Yield	0.28%	0.23%	-0.19%	-	-	-
Dividend Yield	0.11%	0.07%	0.09%	-	-	-
Payout Ratio	1.76%	4.06%	2.88%	-	-	-
Buyback Yield / Dilution	-3.88%	-4.28%	-38.35%	-2.10%	-	-
Total Shareholder Return	-3.77%	-4.21%	-38.27%	-2.10%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.